miRNA in situ hybridization in circulating tumor cells - MishCTC-Reference-Cited by-同舟云学术

miRNA in situ hybridization in circulating tumor cells - MishCTC

Published:2015-03-17 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ortega Francisco G.,Lorente Jose A.,Garcia Puche Jose L.,Ruiz Maria P.,Sanchez-Martin Rosario M.,de Miguel-Pérez Diego,Diaz-Mochon Juan J.,Serrano Maria J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep09207.pdf

Reference23 articles.

1. Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 6, 449–458 (2006).

2. Nadal, R., Lorente, J. A., Rosell, R. & Serrano, M. J. Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies. Expert Rev. Mol. Diagn. 13, 295–307 (2013).

3. Cristofanilli, M. et al. Circulating Tumor Cells, Disease Progression and Survival in Metastatic Breast Cancer. New Engl. J. Med. 351, 781–791 (2004).

4. Schulze, K. et al. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int. J. Cancer. 133, 2165–2171 (2013).

5. Zhao, S. et al. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19 and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients. Cell Biochem. Biophys. 65, 263–273 (2013).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor Cells: How Far Have We Come with Mining These Seeds of Metastasis?;Cancers;2024-02-17

2. Meta analysis of the diagnostic value of circulating miRNA in benign and malignant pulmonary nodules;World Journal of Surgical Oncology;2023-09-09

3. Meta-analysis of the Diagnostic Value of Circulating miRNAs for the Diagnosis of Benign and Malignant Lung Nodules;2023-03-29

4. Clinical Perspectives in the Use of Liquid Biopsy in Metastatic Breast Cancer;Circulating Tumor Cells;2023

5. New horizons in the identification of circulating tumor cells (CTCs): An emerging paradigm shift in cytosensors;Biosensors and Bioelectronics;2022-05